Europe Automated Breast Ultrasound Systems (ABUS) Market size was valued at USD 144.6 million in 2017 and is expected to witness 12.6% CAGR from 2018 to 2024.
Germany Automated Breast Ultrasound Systems (ABUS) Market, By Product, 2013 – 2024 (USD Million)
Rising incidence of breast cancer in Europe will stimulate automated breast ultrasound (ABUS) market growth. Breast cancer is the highly prevalent form of cancer in females, with 28% of the total in the WHO European region. Breast cancer also contributes to the highest deaths across the region. In addition, rise in number of risk factors such as reduced child bearing, increasing obesity, hormonal factors, and alcohol abuse accelerate breast cancer incidence, thereby escalating product demand. ABUS being an effective and more efficient screening technology than mammography system. This will further augment business revenue size in upcoming period.
Technological advancements in ABUS will act as high impacting factor for European ABUS industry growth. Advancements and innovation in cancer screening devices is rising in developed countries. Introduction of imaging technology that generates 3D images will lead to high-quality screening and diagnosis of breast cancer. For instance, Siemens launched Acuson S2000 Automated Breast Volume Scanner that increases reproducibility and sensitivity of 3D images and spots small cancer tumors in less time. Such innovations will positively impact market growth.
Automated Breast Volume Scanner (ABVS) accounted for largest market share of 58.6% in 2017. High market share can be attributable to high-quality and reliable outcomes. It offers results within 10 minutes that will assist increase in customer preference for the product. Greater precision and operator independency will generate high product demand over the forecast years.
Hospitals segment held a revenue of USD 81.3 million in 2017. Growing number of hospitals coupled with increasing awareness about dense breast tissues will assist rise in patient diagnosis. Availability of sophisticated infrastructure along with skilled professionals in hospital set-up will further augment segmental growth over the coming years.
Germany automated breast ultrasound systems market will witness robust growth at 12.2% CAGR. Rapid growth is credited to rising prevalence of breast cancer in the country. Free breast cancer screening across the country will escalate customer adoption of screening tests. Furthermore, growing healthcare facilities will propel regional growth during the forecast period.
Major industry players operating in automated breast ultrasound systems market include GE Healthcare, Koninklijke Philips N.V., Hitachi Ltd., Siemens AG, and SonoCine Inc.. Firms are adopting strategies such as partnerships and collaborations to fortify product base and expand customer reach.
The first model of ABUS was introduced by Siemens, known as Acuson S2000 Automated Breast Volume Scanner (ABVS) in few countries of Europe. In 2011, somo.v ABUS system was the sole system approved in 27 of the European countries. Further, technological advancements by industry competitors marked business revenue growth in Europe due to its effective screening of breast cancer in dense breast tissues than mammography systems. Growing incidence of breast cancer and rising awareness are driving demand for ABUS. Implementation of national screening programs and government initiatives will result into rapid market expansion in forthcoming years.
Segments Covered in this Report:
Europe Automated Breast Ultrasound Systems Market by Product
Europe Automated Breast Ultrasound Systems Market by End-use
The above information is provided for the following countries: